COVID-19 vaccines are in high demand, and there aren’t enough of them. Some countries have yet to receive a single dose. In Canada, a company is testing out an unusual approach to expand the supply to places with less access. It wants to make a vaccine on its own, one that it didn’t develop. As The World’s Elana Gordon reports, this unusual move is adding to a fierce global debate about who controls vaccine knowledge and production in a pandemic.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.